Shoden® Ashwagandha

What makes Shoden® different from regular Ashwagandha?

Shoden® is standardized to 35% glycowithanolides, the glycosidic form of withanolides. Glycosides demonstrate improved absorption and slower metabolism compared to aglycone forms, resulting in enhanced systemic availability at lower doses.

How is Shoden® different from KSM-66® Ashwagandha?

Both Shoden® and KSM-66® are branded extracts of Withania somnifera, but they differ significantly in standardization, bioactive profile, and dosage strength. KSM-66® is typically standardized to ~5% total withanolides and is derived primarily from the root. Shoden® is standardized to 35% glycowithanolides — the glycosidic form of withanolides — resulting in a more concentrated and defined bioactive profile per milligram. Glycowithanolides demonstrate improved water solubility, enhanced absorption, and slower metabolism compared to aglycone-dominant extracts. Clinical pharmacokinetic data on Shoden® shows higher peak plasma concentration and longer systemic presence at a lower daily dose (120 mg).

Why is the dose only 120 mg?

Because Shoden® contains a highly concentrated 35% glycowithanolide profile, meaningful systemic exposure can be achieved at 120 mg per day. This reflects precision standardization rather than higher raw dosage.

What are glycowithanolides?

Glycowithanolides are withanolides bound to a sugar molecule. This glycosidic structure improves water solubility and absorption. Once absorbed, the active withanolide is released in the body.

Is this suitable for athletes?

Yes. Shoden® may be used by athletes and active individuals seeking structured adaptogenic support alongside training, recovery, and performance cycles.